Dataset: Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia.

Transcriptome profile of highly purified multipotential (P), erythroid (E), and myeloid (M) bone marrow progenitors from three RPS19...

Registered by ArrayExpress Uploader

View Dataset

Transcriptome profile of highly purified multipotential (P), erythroid (E), and myeloid (M) bone marrow progenitors from three RPS19 mutated Diamond-Blackfan anemia and six control human subjects. Two group comparison of sex and age matched subjects. Bone marrow progenitors, gene expression profiling, Diamond-Blackfan anemia, RPS19

Species:: human
Samples:: 27
Source:: E-GEOD-41599
PubMed:: 16741228
Updated:: Dec.12, 2014
Registered:: Jun.18, 2014

Factors: (via ArrayExpress)

Sample	SEX	DISEASE STATUS	AGE	SUBJECT ID	CELL TYPE
GSM1019956	male	DiamondâBlackfan anemia	42 year old	D3	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019955	male	DiamondâBlackfan anemia	42 year old	D3	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019954	male	DiamondâBlackfan anemia	42 year old	D3	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019953	male	DiamondâBlackfan anemia	30 year old	D2	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019952	male	DiamondâBlackfan anemia	30 year old	D2	myeloid M, CD34+, CD71 low, CD45RA+
GSM101995	male	DiamondâBlackfan anemia	30 year old	D2	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019950	female	DiamondâBlackfan anemia	46 year old	D1	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019949	female	DiamondâBlackfan anemia	46 year old	D1	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019948	female	DiamondâBlackfan anemia	46 year old	D1	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019947	female	control	between 25 and 40 years old	C6	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019946	female	control	between 25 and 40 years old	C6	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019945	female	control	between 25 and 40 years old	C6	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019944	female	control	between 25 and 40 years old	C5	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019943	female	control	between 25 and 40 years old	C5	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019942	female	control	between 25 and 40 years old	C5	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM101994	female	control	between 25 and 40 years old	C4	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019940	female	control	between 25 and 40 years old	C4	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019939	female	control	between 25 and 40 years old	C4	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019938	female	control	between 25 and 40 years old	C3	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019937	female	control	between 25 and 40 years old	C3	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019936	female	control	between 25 and 40 years old	C3	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019935	male	control	between 25 and 40 years old	C2	multipotential P, CD34+, CD71â, CD45RAâ
GSM1019934	male	control	between 25 and 40 years old	C2	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019933	male	control	between 25 and 40 years old	C2	erythroid E, CD34+, CD71 hi, CD45RAâ
GSM1019932	female	control	between 25 and 40 years old	C1	multipotential P, CD34+, CD71â, CD45RAâ
GSM101993	female	control	between 25 and 40 years old	C1	myeloid M, CD34+, CD71 low, CD45RA+
GSM1019930	female	control	between 25 and 40 years old	C1	erythroid E, CD34+, CD71 hi, CD45RAâ